Table 2.
Author (year)Ref. | All patients | Stage I | Stage II1 | Median follow‐up (months) | Relapse (%) | Treatment failurea (%) | |||
---|---|---|---|---|---|---|---|---|---|
No . | CR cases (%) | No. | CR cases (%) | No. | CR cases (%) | ||||
Pinotti (1997)26 | 49 | 30 (61) | 49 | 30 (61) | 0 | ‐ | 22 | 2 (6.6) | 5 (10) |
Savio (2000)27 | 76 | 71 (93) | 75 | 71 (95) | 1 | 0 | 28 | 6 (8.5) | 6 (7.9) |
Wündisch (2006)20 | 196 | 146 (75) | 193 | 146 (76) | 0 | ‐ | 27 | 5 (3.4) | 18 (9.2) |
Nakamura (2008)28 | 70 | 55 (79) | 65 | 54 (83) | 5 | 1 (20) | 46 | 1 (1.8) | 10 (14) |
Stathis (2009)21 | 85 | 66 (78) | 80 | 66 (83) | 5 | 0 | 76 | 16 (24) | 23 (27) |
Andriani (2009)29 | 60 | 42 (70) | 44 | 37 (84) | 9 | 5 (56) | 65 | 13 (31) | 16 (27) |
Ono (2010)12 | 50 | 48 (96) | 43 | 42 (98) | 7 | 6 (86) | 76 | 0 | 2 (4.0) |
Nakamura (2012)15 | 376 | 317 (84) | 378 | 304 (80) | 35 | 17 (49) | 72 | 10 (3.2) | 37 (9.8) |
Moleiro (2016)22 | 93 | 77 (83) | 82 | 73 (89) | 11 | 4 (36) | 109 | 11 (14) | 27 (29) |
Total | 1055 | 852 (81) | 1009 | 823 (82) | 73 | 33 (45) | 65 | 64 (7.5) | 144 (14) |
CR, complete remission.
Relapse, progressive disease, and/or non‐CR at 6 months after eradication.